Clinic Dispensing, Dispensing Solution, Doctor Dispensing, In Office Dispensing, Physician Dispensing

Three Reasons Drug Dispensing Should Be On Your Radar

Considering dispensing medications from your clinic?  Physician dispensing could be a great complement to the services your already provide to your patients.

Here are three reasons offering pharmaceuticals from your clinic is a win/win for you and your patients:

1. Extra income – depending on the size and patient mix within your practice, clinic dispensing can generate $20,000 – $50,000 per practitioner annually.  Done properly, you won’t need to add staff or change much in your care flow.

2. Patient satisfaction – it can be a real hassle for a patient to make another stop after leaving the clinic. Giving the patient her prescription before she leaves simplifies her life and gets her on the path to feeling better even faster.

3. Clinic appeal – Let’s face it, competition is intense.  Attracting new patients and keeping the ones you have can be a challenge.  Obviously, job one is great care for your patient.  However, offering complementary products or services can be a great way to attract new patients and keep your current ones coming back.

Still hesitant?  Consider this: providers are implementing clinic dispensing at a rapid rate.  Specialists and general practitioners are providing medications to patients more and more to provide a complete solution.  If you don’t have medical dispensing on your radar, just remember, your competition does.

Schedule a free claims analysis now.

Let’s Talk now

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading